Bioxyne Ltd has released a press release.
Retirement of Director
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Bioxyne
- BLS Extends Amazon Footprint into US and Japan
- BXN to Acquire Health & Wellness Co Breathe Life Sciences
- Joins Asian Partner & Sells 49% of Direct Selling Business
- Appendix 4D and Interim Report
- Reinstatement to Official Quotation
Later from Bioxyne
- BXN Awarded GMP Manufacturing License for Medical Cannabis
- BXN Manufactures First Pharmaceutical Cannabis Gummies
- Response to ASX Query Letter
- Suspension from Official Quotation
- Announcement 21.8.2024 Clarifying Statement
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne